BS220-5-SP-CO:
Medical Genetics
2022/23
Life Sciences (School of)
Colchester Campus
Spring
Undergraduate: Level 5
Current
Monday 16 January 2023
Friday 24 March 2023
15
31 March 2021
Requisites for this module
(none)
(none)
(none)
(none)
(none)
BSC B990 Biomedical Science,
BSC B991 Applied Biomedical Science (NHS placement),
BSC B995 Biomedical Science (Including Year Abroad),
BSC B999 Biomedical Science (Including Placement Year),
BSC BD00 Biomedical Science (Including Foundation Year),
MSCIB099 Biomedical Science,
MSCIBA99 Biomedical Science (Including Placement Year),
MSCIBB99 Biomedical Science (Including Year Abroad)
This module aims to provide an introduction to the field of human genetics from understanding the molecular basis of genetic disease, to the application of techniques for genome analysis in the clinical genetics laboratory. The inheritance of single gene diseases and more complex multifactorial disorders will be addressed.
The types of abnormalities found in the human karyotype will be studied. The origins and types of defects observed, their effect at a molecular level and on the individuals and families affected will be considered. The impact of the human genome project, molecular diagnostic techniques and potential therapeutic options such as gene therapy will be considered.
The module aims to:
1. Explain the significance of an individual`s genetic make-up in their risk of inherited and common disease, how the development of gene and genome sequencing has led to greater understanding of the role of genes and genetic variation, and how `high-throughput` rapid and cheap methods to sequence DNA are becoming embedded in the National Health Service in the UK
2. Explain the inheritance patterns of recessive, dominant and X-linked Mendelian genetic diseases using appropriate terminology, understanding the statistical likelihood that relatives are affected or carriers
3. For named examples of Mendelian genetic disorders, describe the incidence and clinical features, explain the causative mutations and how they result in disease by impacting on the structure and function of the normal gene product.
4. Describe the UK neonatal (new-born) blood spot screening programme for genetic disorders, the key diseases screened, and interventions or treatments applied
5. Describe examples of neurodegenerative disorders caused by coding sequence CAG expansion and explain the molecular pathology of triplet repeat disorders, including inheritance and anticipation
6. Explain the structure, function and inheritance of the human mitochondrial genome
7. Explain examples of mitochondrial genetic disease and the complexity of diagnosis and transmission of mitochondrial disorders
8. Explain how `three-parent` IVF may allow parents with mitochondrial mutations to have unaffected children
9. Explain the applications of genetic testing in the context of families and populations
10. Describe the methods used to identify genetic disease alleles, including DNA sequencing, Southern blotting and PCR-based approaches
11. Discuss the relevance of animal models for human disease
12. Describe the generation of transgenic and `knock-out` mice
13. Describe the use of genetically manipulated mice in studies of disease
14. Discuss the general approaches used for gene therapy
15. Describe the viral and non-viral methods of gene delivery
16. Describe the characteristics of oncogenes and tumour suppressor genes
17. Describe the ways in which proto-oncogenes can be activated into oncogenes
18. Describe the role of important oncogenes and TS genes in cancer development (with reference to specific examples)
19. Discuss the involvement of genetic predisposition in the development of cancers
20. Describe an example in which genetic screening for cancers can impact on the treatment given
21. Discuss the general approaches used for cancer gene therapy
22. Understand the role of cytogenetics in the development of cancers
23. Discuss an example of a chromosomal translocation that causes cancer
24. Describe the normal human karyotype and explain how errors in chromosome number arise
25. Describe examples of the common types of trisomy found in humans
26. Explain the techniques used to study the chromosome content of cells and to investigate abnormalities of chromosome number and structure, including FISH, MLPA and array CGH
27. Explain the process of prenatal screening for Down syndrome: maternal blood tests, ultrasound and karyotype analysis
28. Discuss the advantages and disadvantages of CVS, amniocentesis and the new non-invasive (NIPT) approaches being developed
29. Describe how chromosome structural abnormalities can lead to syndromes such as cri-du-chat and Charcot-Marie-Tooth disease, or to developmental delay
30. Explain the interaction of genetics and environment in determining the risk of complex diseases
31. Explain the approaches used to study complex diseases, including twin, family and population (genome wide association) studies
32. Explain the basis of genetic predisposition and environmental factors in the development of disease in asthma, coronary heart disease and atherosclerosis
33. Explain how recent developments in DNA analysis are setting a new agenda in approaches to predicting and treating human disease, including pharmacogenetics, precision medicine and gene editing
And by completing the relevant practical assessments:
35. Access the key online sources for information about human genetic disease, such as OMIM (Online Mendelian Inheritance in Man), conduct BLAST searches of the databases storing human gene and protein sequences, and know how to use some of the tools available to investigate them (translating, aligning).
36. Apply the molecular methods of DNA extraction, PCR, restriction enzyme digestion and gel electrophoresis to investigate a human mitochondrial DNA polymorphism (RFLP), then to present and interpret critically the data to identify the alleles present.
At the end of this module students will be able to:
1. define the structure and organisation of the human genome and genes and explain modern methods used to study genome variation and expression;
2. explain the nature of single gene and complex genetic disease, including the mechanisms of disease and the inheritance patterns observed;
3. explain the mechanisms leading to abnormalities in the human karyotype, the resulting disorders and the molecular techniques used to study chromosomes;
4. valuate the different genetic screening tests, when they are applied and their application in genetic counselling;
5. demonstrate competence in information retrieval and data analysis and interpretation.
No additional information available.
18 hours lectures
2 x 3 hours practicals
2 hours revision
This module does not appear to have a published bibliography for this year.
Assessment items, weightings and deadlines
| Coursework / exam |
Description |
Deadline |
Coursework weighting |
| Coursework |
Prac 1 Worksheet - Bioinformatics |
|
40% |
| Coursework |
Prac 2 Worksheet - DNA |
|
60% |
| Exam |
Main exam: In-Person, Open Book (Restricted), 120 minutes during Summer (Main Period)
|
| Exam |
Reassessment Main exam: In-Person, Open Book (Restricted), 120 minutes during September (Reassessment Period)
|
Exam format definitions
- Remote, open book: Your exam will take place remotely via an online learning platform. You may refer to any physical or electronic materials during the exam.
- In-person, open book: Your exam will take place on campus under invigilation. You may refer to any physical materials such as paper study notes or a textbook during the exam. Electronic devices may not be used in the exam.
- In-person, open book (restricted): The exam will take place on campus under invigilation. You may refer only to specific physical materials such as a named textbook during the exam. Permitted materials will be specified by your department. Electronic devices may not be used in the exam.
- In-person, closed book: The exam will take place on campus under invigilation. You may not refer to any physical materials or electronic devices during the exam. There may be times when a paper dictionary,
for example, may be permitted in an otherwise closed book exam. Any exceptions will be specified by your department.
Your department will provide further guidance before your exams.
Overall assessment
Reassessment
Module supervisor and teaching staff
Dr Patrick Varga Weisz, email: patrick.varga-weisz@essex.ac.uk.
Dr Vladimir Teif, Dr Patrick Varga Weisz
School Undergraduate Office, email: bsugoffice (Non essex users should add @essex.ac.uk to create the full email address)
Yes
No
No
Prof Jacqueline McCormack
Institute Technology Sligo
Vice President
Available via Moodle
Of 36 hours, 30 (83.3%) hours available to students:
6 hours not recorded due to service coverage or fault;
0 hours not recorded due to opt-out by lecturer(s), module, or event type.
Disclaimer: The University makes every effort to ensure that this information on its Module Directory is accurate and up-to-date. Exceptionally it can
be necessary to make changes, for example to programmes, modules, facilities or fees. Examples of such reasons might include a change of law or regulatory requirements,
industrial action, lack of demand, departure of key personnel, change in government policy, or withdrawal/reduction of funding. Changes to modules may for example consist
of variations to the content and method of delivery or assessment of modules and other services, to discontinue modules and other services and to merge or combine modules.
The University will endeavour to keep such changes to a minimum, and will also keep students informed appropriately by updating our programme specifications and module directory.
The full Procedures, Rules and Regulations of the University governing how it operates are set out in the Charter, Statutes and Ordinances and in the University Regulations, Policy and Procedures.